caprylates has been researched along with Bacterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, K; Fromme, H; Menzel, J; Mielke, H; Peiser, M; Völkel, W; Weikert, C; Willich, SN; Zepp, F | 1 |
| Lebing, W; Paul, HI; Remington, KM; Schreiner, C | 1 |
| Grimont, F; Grimont, PA; Starr, MP; Starr, PB | 1 |
3 other study(ies) available for caprylates and Bacterial Disease
| Article | Year |
|---|---|
Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response.
Topics: Alkanesulfonic Acids; Antibodies, Bacterial; Bacterial Infections; Bacterial Vaccines; Body Burden; Bottle Feeding; Breast Feeding; Caprylates; Cells, Cultured; Cross-Sectional Studies; Diphtheria Toxoid; Environmental Pollutants; Female; Fluorocarbons; Haemophilus Vaccines; Humans; Immunity, Cellular; Immunogenicity, Vaccine; Infant; Infant Formula; Interferon-gamma; Lymphocytes; Male; No-Observed-Adverse-Effect Level; Tetanus Toxoid; Vaccination | 2020 |
Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography.
Topics: Animals; Bacterial Infections; Caprylates; Chemical Precipitation; Chromatography; Disinfection; Drug Contamination; Drug Industry; Humans; Immunoglobulins, Intravenous; Mice; Survival Rate; Virus Diseases; Viruses | 2003 |
Caprylate-thallous agar medium for selectively isolating Serratia and its utility in the clinical laboratory.
Topics: Agar; Bacterial Infections; Caprylates; Cross Infection; Evaluation Studies as Topic; Feces; Humans; Serratia; Species Specificity; Sputum; Thallium; Urine | 1976 |